These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16279713)

  • 1. [Osteopontin in rheumatoid arthritis].
    Saeki Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():627-31. PubMed ID: 16279713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
    Suzuki Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoclastic bone resorption in joint destruction of rheumatoid arthritis].
    Kawaguchi H
    Ryumachi; 2000 Feb; 40(1):32-8. PubMed ID: 10783664
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
    Tanaka S; Nakamura K; Takahasi N; Suda T
    Immunol Rev; 2005 Dec; 208():30-49. PubMed ID: 16313339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BMP and osteoclastogenesis].
    Nakamura M; Udagawa N; Yamamoto Y; Nakamura H
    Clin Calcium; 2006 May; 16(5):809-15. PubMed ID: 16679623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
    Hikita A; Tanaka S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
    [No Abstract]   [Full Text] [Related]  

  • 7. RANKL-mediated osteoclast formation from murine RAW 264.7 cells.
    Collin-Osdoby P; Yu X; Zheng H; Osdoby P
    Methods Mol Med; 2003; 80():153-66. PubMed ID: 12728717
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecules which are involved in osteoclastic bone resorption: from the aspect of targets of treatment for osteoporosis].
    Take I; Takahash N; Kurihara S
    Clin Calcium; 2005 May; 15(5):741-6. PubMed ID: 15876734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of the bone destruction in rheumatoid arthritis].
    Nakamura M; Tanaka S
    Nihon Rinsho; 2005 Sep; 63(9):1571-3. PubMed ID: 16164213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin as a positive regulator in the osteoclastogenesis of arthritis.
    Ishii T; Ohshima S; Ishida T; Mima T; Tabunoki Y; Kobayashi H; Maeda M; Uede T; Liaw L; Kinoshita N; Kawase I; Saeki Y
    Biochem Biophys Res Commun; 2004 Apr; 316(3):809-15. PubMed ID: 15033472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC; Crotti TN; Goldring SR; Gravallese EM
    Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteopontin in rheumatoid arthritis].
    Noda M; Inoue K; Kondo H; Yumoto K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():185-8. PubMed ID: 15799343
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Commitment and differentiation of osteoclast on stromal cells].
    Yamazaki H; Hayashi S
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(7):854-64. PubMed ID: 10380577
    [No Abstract]   [Full Text] [Related]  

  • 15. [The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption].
    Yamamoto Y; Noguchi T; Udagawa N
    Clin Calcium; 2005 Jul; 15(7):11-6. PubMed ID: 15995290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone disease related to rheumatoid arthritis].
    Tanaka S
    Nihon Rinsho; 2006 Sep; 64(9):1712-7. PubMed ID: 16972685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications.
    Anandarajah AP; Schwarz EM
    J Cell Biochem; 2006 Feb; 97(2):226-32. PubMed ID: 16240334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of bone involvement in patients with rheumatoid arthritis].
    Lewicki M; Lewicka K; Goździk J; Kucharz EJ
    Przegl Lek; 2002; 59(11):912-5. PubMed ID: 12715721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible roles of TNF family cytokines in bone destruction of rheumatoid arthritis].
    Udagawa N; Kotake S; Kamatani N; Takahashi N; Suda T
    Ryumachi; 2002 Feb; 42(1):3-12. PubMed ID: 11925905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.